Estrella Immunopharma, Inc.
ESLA
$1.15
$0.021.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.23% | -14.90% | 23.55% | 212.36% | -54.03% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.49% | -26.25% | 142.16% | -68.65% | -27.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.63% | -17.12% | 36.68% | 56.78% | -42.45% |
|
|
|||||
| Total Current Assets | 28.63% | -17.12% | 36.68% | 56.78% | -42.45% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 15.11% | -9.83% | 18.22% | 21.94% | -22.18% |
|
|
|||||
| Total Accounts Payable | -97.31% | 9,807.14% | -31.71% | -41.43% | 218.18% |
| Total Accrued Expenses | -33.01% | -2.76% | 46.08% | 108.92% | 42.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 50.00% | 0.00% | -60.00% | 150.00% |
| Total Finance Division Other Current Liabilities | 24.35% | -2.62% | 105.11% | 5,593.94% | -69.16% |
| Total Other Current Liabilities | 24.35% | -2.62% | 105.11% | 5,593.94% | -69.16% |
| Total Current Liabilities | -34.08% | 1.37% | 47.21% | 112.28% | 42.65% |
|
|
|||||
| Total Current Liabilities | -34.08% | 1.37% | 47.21% | 112.28% | 42.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -34.08% | 1.37% | 47.21% | 112.28% | 42.65% |
|
|
|||||
| Common Stock & APIC | 27.14% | 0.31% | 4.06% | 5.17% | 0.65% |
| Retained Earnings | -6.20% | -1.69% | -15.20% | -21.30% | -8.79% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | -5.19% |
| Total Common Equity | 49.16% | -5.39% | -61.39% | -232.88% | -1,374.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 49.16% | -5.39% | -61.39% | -232.88% | -1,374.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 49.16% | -5.39% | -61.39% | -232.88% | -1,374.11% |
|
|
|||||